94 related articles for article (PubMed ID: 20170347)
1. Micronucleus frequency in lymphocytes and 8-hydroxydeoxyguanosine level in plasma of women with polycystic ovary syndrome.
Hamurcu Z; Bayram F; Kahriman G; Dönmez-Altuntas H; Baskol G
Gynecol Endocrinol; 2010 Aug; 26(8):590-5. PubMed ID: 20170347
[TBL] [Abstract][Full Text] [Related]
2. Chromosomal aberrations level in peripheral blood lymphocytes of women with polycystic ovary syndrome.
Nersesyan A; Martirosyan A; Parsadanyan G; Zalinyan G
J BUON; 2006; 11(4):477-80. PubMed ID: 17309180
[TBL] [Abstract][Full Text] [Related]
3. Genome instability is increased in lymphocytes of women with polycystic ovary syndrome and is correlated with insulin resistance.
Moran LJ; Noakes M; Clifton PM; Norman RJ; Fenech MF
Mutat Res; 2008 Mar; 639(1-2):55-63. PubMed ID: 18178226
[TBL] [Abstract][Full Text] [Related]
4. Distinctively low levels of serum 8-hydroxydeoxyguanosine in women with polycystic ovary syndrome.
Sova H; Morin-Papunen L; Puistola U; Karihtala P
Fertil Steril; 2010 Dec; 94(7):2670-3. PubMed ID: 20430377
[TBL] [Abstract][Full Text] [Related]
5. Micronuclei and other nuclear anomalies levels in exfoliated buccal cells and DNA damage in leukocytes of patients with polycystic ovary syndrome.
Nersesyan A; Chobanyan N
J BUON; 2010; 15(2):337-9. PubMed ID: 20658732
[TBL] [Abstract][Full Text] [Related]
6. Oxidative stress but not endothelial dysfunction exists in non-obese, young group of patients with polycystic ovary syndrome.
Kuşçu NK; Var A
Acta Obstet Gynecol Scand; 2009; 88(5):612-7. PubMed ID: 19308750
[TBL] [Abstract][Full Text] [Related]
7. Increased serum advanced glycation end-products is a distinct finding in lean women with polycystic ovary syndrome (PCOS).
Diamanti-Kandarakis E; Katsikis I; Piperi C; Kandaraki E; Piouka A; Papavassiliou AG; Panidis D
Clin Endocrinol (Oxf); 2008 Oct; 69(4):634-41. PubMed ID: 18363886
[TBL] [Abstract][Full Text] [Related]
8. [Insulin release and daily glucose change in polycystic ovary syndrome women with normal glucose tolerance].
Tao MF; Zhu JP; Zhou J; Lu W; Qin W; Teng YC; Jia WP
Zhonghua Yi Xue Za Zhi; 2009 Mar; 89(10):659-63. PubMed ID: 19595057
[TBL] [Abstract][Full Text] [Related]
9. Insulin response to oral glucose in healthy, lean young women and patients with polycystic ovary syndrome.
Kulshreshtha B; Ganie MA; Praveen EP; Gupta N; Lal Khurana M; Seith A; Dwivedi SN; Kumar G; Ammini AC
Gynecol Endocrinol; 2008 Nov; 24(11):637-43. PubMed ID: 19031221
[TBL] [Abstract][Full Text] [Related]
10. Increased genome instability and oxidative DNA damage and their association with IGF-1 levels in patients with active acromegaly.
Bayram F; Bitgen N; Donmez-Altuntas H; Cakir I; Hamurcu Z; Sahin F; Simsek Y; Baskol G
Growth Horm IGF Res; 2014 Feb; 24(1):29-34. PubMed ID: 24382376
[TBL] [Abstract][Full Text] [Related]
11. Diagnostic potential of serum N-terminal pro-B-type brain natriuretic peptide level in detection of cardiac wall stress in women with polycystic ovary syndrome: a cross-sectional comparison study.
Celik O; Sahin I; Celik N; Hascalik S; Keskin L; Ozcan H; Uckan A; Kosar F
Hum Reprod; 2007 Nov; 22(11):2992-8. PubMed ID: 17855407
[TBL] [Abstract][Full Text] [Related]
12. Decreased adiponectin levels in polycystic ovary syndrome, independent of body mass index.
Sharifi F; Hajihosseini R; Mazloomi S; Amirmogaddami H; Nazem H
Metab Syndr Relat Disord; 2010 Feb; 8(1):47-52. PubMed ID: 19929617
[TBL] [Abstract][Full Text] [Related]
13. Increased salivary level of 8-hydroxydeoxyguanosine is a marker of premature oxidative mitochondrial DNA damage in gingival tissue of patients with periodontitis.
Canakçi CF; Canakçi V; Tatar A; Eltas A; Sezer U; Ciçek Y; Oztas S
Arch Immunol Ther Exp (Warsz); 2009; 57(3):205-11. PubMed ID: 19479201
[TBL] [Abstract][Full Text] [Related]
14. Evaluation of chromosomal damage, cytostasis, cytotoxicity, oxidative DNA damage and their association with body-mass index in obese subjects.
Donmez-Altuntas H; Sahin F; Bayram F; Bitgen N; Mert M; Guclu K; Hamurcu Z; Arıbas S; Gundogan K; Diri H
Mutat Res Genet Toxicol Environ Mutagen; 2014 Sep; 771():30-6. PubMed ID: 25308439
[TBL] [Abstract][Full Text] [Related]
15. Atherogenic forms of dyslipidaemia in women with polycystic ovary syndrome.
Berneis K; Rizzo M; Hersberger M; Rini GB; Di Fede G; Pepe I; Spinas GA; Carmina E
Int J Clin Pract; 2009 Jan; 63(1):56-62. PubMed ID: 19125993
[TBL] [Abstract][Full Text] [Related]
16. Circadian variation in multiple sclerosis of oxidative stress marker of DNA damage. A potential cancer marker?
Kanabrocki EL; Ryan MD; Murray D; Jacobs RW; Wang J; Hurder A; Friedman NC; Siegel G; Eladasari B; Nemchausky BA; Cornelissen G; Halberg F
Clin Ter; 2006; 157(2):117-22. PubMed ID: 16817500
[TBL] [Abstract][Full Text] [Related]
17. Tryptophan 64 --> arginine polymorphism of beta-3-adrenergic receptor in Chilean women with polycystic ovary syndrome.
Pérez-Bravo F; Echiburú B; Maliqueo M; Santos JL; Sir-Petermann T
Clin Endocrinol (Oxf); 2005 Feb; 62(2):126-31. PubMed ID: 15670186
[TBL] [Abstract][Full Text] [Related]
18. Neuropeptide Y, leptin, galanin and insulin in women with polycystic ovary syndrome.
Baranowska B; Radzikowska M; Wasilewska-Dziubińska E; Kapliński A; Roguski K; Płonowski A
Gynecol Endocrinol; 1999 Oct; 13(5):344-51. PubMed ID: 10599552
[TBL] [Abstract][Full Text] [Related]
19. Body fat composition and distribution in women with polycystic ovary syndrome.
Cosar E; Uçok K; Akgün L; Köken G; Sahin FK; Arioz DT; Baş O
Gynecol Endocrinol; 2008 Aug; 24(8):428-32. PubMed ID: 18850379
[TBL] [Abstract][Full Text] [Related]
20. Postprandial response of ghrelin and PYY and indices of low-grade chronic inflammation in lean young women with polycystic ovary syndrome.
Zwirska-Korczala K; Sodowski K; Konturek SJ; Kuka D; Kukla M; Brzozowski T; Cnota W; Woźniak-Grygiel E; Jaworek J; Bułdak R; Rybus-Kalinowska B; Fryczowski M
J Physiol Pharmacol; 2008 Aug; 59 Suppl 2():161-78. PubMed ID: 18812636
[TBL] [Abstract][Full Text] [Related]
[Next] [New Search]
